Workflow
Allot Communications (ALLT) Is a Great Choice for 'Trend' Investors, Here's Why
ZACKS· 2025-06-11 13:50
While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy.Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, ...
Cabaletta Bio: Sector Headwinds And Funding Issues
Seeking Alpha· 2025-06-11 13:49
Cabaletta Bio (NASDAQ: CABA ) is a company I've covered with tentative optimism, given their signals of efficacy for an approach that the medical community is gaining increasing experience with. Today, I want to take another lookI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by ...
RKLB Breakout Fails Near Highs: Should Investors Be Concerned?
MarketBeat· 2025-06-11 13:47
Core Viewpoint - Rocket Lab USA (RKLB) has experienced significant stock price growth, rising over 500% in the past year, driven by increased investor interest in space innovation and defense contracts [1][10]. Stock Performance - RKLB shares recently approached an all-time high, trading around $27.40, but faced a pullback after a failed breakout above $30 [1][4]. - Following a public feud between Elon Musk and Donald Trump, RKLB's stock surged over 6% in after-hours trading, but gains were quickly reversed as tensions eased [2][3]. Technical Analysis - The stock remains above major moving averages and key support levels, with a recent higher low at $25 acting as critical support [6][11]. - A consolidation in the $27 to $30 range could lead to a retest of $30 and potential new all-time highs [6][11]. Fundamental Strength - Rocket Lab's acquisition of Geost is a strategic move to enhance its position in the defense sector, praised by analysts for broadening its reach [8][10]. - The upcoming launch of the Neutron rocket, with a payload capacity of up to 13,000 kg, is expected to significantly enhance Rocket Lab's competitiveness in the satellite launch market [9][10]. Market Opportunities - The Neutron rocket positions Rocket Lab to bid for high-value government contracts, including the National Security Space Launch (NSSL) Phase 3 Lane 1 contracts, potentially worth up to $5.6 billion [10]. - Despite recent technical setbacks, the overall market trends and fundamentals suggest a strong long-term trajectory for Rocket Lab [11].
EPAM Systems: Quiet Rebuild, Strategic Upside And A Patient Investor's Opportunity
Seeking Alpha· 2025-06-11 13:45
EPAM Systems (NYSE: EPAM ) has not recovered really from the Russia and Ukraine exposure since 2022. The company has been quietly rebuilding its workforce, relocated staff from the regions, acquiring and building capabilities and even showing signs of returning growth. TheI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportuni ...
Buy or Sell HOOD Stock At $72
Forbes· 2025-06-11 13:45
Core Viewpoint - Robinhood Markets (NASDAQ:HOOD) has experienced a surge of over 25% in the past month due to speculation regarding its potential inclusion in the S&P 500 index, but it was not added in the latest quarterly rebalance, raising questions about its current valuation at $72 and whether it remains a good investment [2][3] Valuation Analysis - The current valuation of Robinhood is considered too high despite minimal fundamental concerns, with a price-to-sales (P/S) ratio of 19.9 compared to 3.0 for the S&P 500, a price-to-free cash flow (P/FCF) ratio of 58.6 versus 20.5 for the S&P 500, and a price-to-earnings (P/E) ratio of 40.9 against 26.4 for the benchmark [8][11] - Robinhood's revenues have grown significantly, with a 59.6% increase from $2.0 billion to $3.3 billion in the last 12 months, and quarterly revenues rising 50.0% to $927 million from $618 million a year ago [8][11] Financial Performance - Robinhood's operating income over the last four quarters was $1.3 billion, resulting in a high operating margin of 39.0%, and a net income of $1.6 billion, indicating a net income margin of 48.8% [14] - The company has a strong balance sheet, with a debt figure of $9.1 billion and a market capitalization of $64 billion, leading to a low debt-to-equity ratio of 14.0% [14] Growth and Profitability - Robinhood has demonstrated extremely strong growth, with an average revenue growth rate of 30.0% over the last three years, significantly outpacing the S&P 500's 5.5% [8][11] - Profit margins are considerably higher than most companies in the Trefis coverage universe, showcasing robust profitability [7][14] Downturn Resilience - HOOD stock has shown extremely weak resilience during downturns, having fallen 90.2% from its peak in August 2021 to June 2022, compared to a 25.4% decline for the S&P 500 [15] - Despite recovering to its pre-crisis peak by June 2025, the stock's performance during downturns raises concerns about its stability [10][15]
Schneider Electric Accelerates the Development and Deployment of AI Factories at Scale With NVIDIA
Globenewswire· 2025-06-11 13:45
●Research and Development initiatives underscore companies’ commitment to co-developing new cooling, power, building management and control systems for digital and physical AI data centers●Partnership will underpin Europe’s AI infrastructure ambitions, aligning with the EU Commission’s ‘AI Continent Action Plan’ and its ‘InvestAI’ initiative●Schneider Electric announces launch of new NVIDIA-enabled rack solution Schneider-Electric_NVIDIA.jpg Schneider-Electric_NVIDIA.jpg Paris, France, June 11, 2025 (GLO ...
Wolters Kluwer completes acquisition of Brightflag
Globenewswire· 2025-06-11 13:45
PRESS RELEASE Wolters Kluwer completes acquisition of Brightflag Alphen aan den Rijn — June 11, 2025 — Wolters Kluwer Legal & Regulatory has today completed the previously announced acquisition of Brightflag, a global provider of legal spend and matter management software. The agreement was originally signed and announced on May 29, 2025. ### About Wolters KluwerWolters Kluwer (EURONEXT: WKL) is a global leader in information solutions, software and services for professionals in healthcare; tax and accounti ...
Yum! Brands: Taco Bell Keeps Cooking, But The Stock Is Already Fully Baked
Seeking Alpha· 2025-06-11 13:44
It’s been four months since my last write-up into Yum! Brands (NYSE: YUM ), one of the titans of the limited-service space—and sureAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock i ...
Cadence Design Systems: Strong Moat And Multiple Growth Drivers
Seeking Alpha· 2025-06-11 13:43
I give a buy rating for Cadence Design Systems (NASDAQ: CDNS ) as I see CDNS benefiting from multiple secular tailwinds, and its moat is getting stronger. Execution has been strong, and demand is showing no signs of slowingI’m a fundamental, valuation-driven investor with a strong focus on identifying businesses that have the potential to scale over time and unlock massive terminal value. My investment approach centers around understanding the core economics of a business—its competitive moat, unit economic ...
Bicara Therapeutics Looks To Reclaim Some Of The Spotlight From Merus
Seeking Alpha· 2025-06-11 13:42
May 23 was a significant day for patients, oncologists and investors in the treatment of head and neck cancer. In preparation for presentations at the American Society of Clinical Oncology, or ASCO, both Bicara Therapeutics Inc. (NASDAQ:I am a private investor based out of Toronto, Canada and I have been investing since 2003. After 8 years in Corporate Finance with a Canadian Telecom company I have decided to dedicate myself full-time to the capital markets. I write on Seeking Alpha to demonstrate my financ ...